Pacira BioSciences (PCRX)
(Real Time Quote from BATS)
$25.57 USD
-0.33 (-1.27%)
Updated Apr 25, 2024 03:12 PM ET
5-Strong Sell of 5 5
B Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/1/24 |
---|---|
Current Quarter | 0.65 |
EPS Last Quarter | 0.89 |
Last EPS Surprise | 0.00% |
ABR | 1.30 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.95 |
Next Year | 3.71 |
EPS (TTM) | 2.92 |
P/E (F1) | 8.78 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 166.11M | 173.80M | 695.09M | 761.97M |
# of Estimates | 7 | 7 | 8 | 8 |
High Estimate | 174.95M | 175.75M | 705.18M | 795.17M |
Low Estimate | 158.68M | 171.65M | 685.07M | 738.42M |
Year ago Sales | 160.34M | 169.47M | 674.98M | 695.09M |
Year over Year Growth Est. | 3.60% | 2.56% | 2.98% | 9.62% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.65 | 0.74 | 2.95 | 3.71 |
# of Estimates | 7 | 7 | 7 | 7 |
Most Recent Consensus | 0.63 | 0.72 | 2.88 | 3.61 |
High Estimate | 0.80 | 0.83 | 3.32 | 4.13 |
Low Estimate | 0.55 | 0.69 | 2.84 | 3.51 |
Year ago EPS | 0.53 | 0.78 | 2.81 | 2.95 |
Year over Year Growth Est. | 22.64% | -5.13% | 4.98% | 25.66% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 5 | 5 | 6 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.65 | 0.74 | 2.95 | 3.71 |
7 Days Ago | 0.65 | 0.74 | 2.95 | 3.71 |
30 Days Ago | 0.65 | 0.74 | 2.95 | 3.71 |
60 Days Ago | 0.77 | 0.84 | 3.41 | 4.25 |
90 Days Ago | 0.83 | 0.90 | 3.94 | 4.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.65 | 0.74 | 2.95 | 3.71 |
Zacks Consensus Estimate | 0.65 | 0.74 | 2.95 | 3.71 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.89 | 0.72 | 0.78 | 0.53 | NA |
Estimate | 0.89 | 0.84 | 0.81 | 0.60 | NA |
Difference | 0.00 | -0.12 | -0.03 | -0.07 | -0.06 |
Surprise | 0.00% | -14.29% | -3.70% | -11.67% | -7.42% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more